Adipokines and ghrelin in gastric cancer cachexia

被引:79
作者
Kerem, Mustafa [1 ]
Ferahkose, Zafer [1 ]
Yilman, Utku Tonguc [1 ]
Pasaoglu, Hatice [2 ]
Ofluoglu, Ebru [2 ]
Bedirli, Abdulkadir [1 ]
Salman, Bulent [1 ]
Sahin, Tevfik Tolga [1 ]
Akin, Murat [1 ]
机构
[1] Gazi Univ, Fac Med, Dept Gen Surg, TR-06510 Ankara, Turkey
[2] Gazi Univ, Fac Med, Dept Biochem, TR-06510 Ankara, Turkey
关键词
gastric cancer; cachexia; resistin; ghrelin; leptin; adiponectin; insuline;
D O I
10.3748/wjg.14.3633
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the roles of the adipocytokines, ghrelin and leptin in gastric cancer cachexia. METHODS: Resistin, ghrelin, leptin, adiponectin, insulin and insulin-like growth factor (IGF-I), were measured in 30 healthy subjects, and 60 gastric cancer patients of which 30 suffered from cancer-induced cachexia and 30 served as a control group. The relationships between hormones, body mass index (BMI) loss ratio, age, gender, and Glasgow Prognostic Score (GPS) were investigated. RESULTS: Cachexia patients had higher tumor stage and GPS when compared with non-cachexia patients (P < 0.05). Ghrelin, resistin, leptin, adiponectin and IGF-I, showed a significant correlation with BMI loss ratio and GPS (P < 0.05). A strong correlation was seen between GPS and BMI loss (R = -0.570, P < 0.0001). Multivariate analysis indicated that BMI loss was significantly independent as a predictor of ghrelin, resistin, leptin and IGF-I (P < 0.05). Existence of an important significant relationship between resistin and insulin resistance was also noted. CONCLUSION: These results showed that serum ghrelin, leptin, adiponectin, and IGF-I play important roles in cachexia-related gastric cancers. No relationship was found between resistin and cancer cachexia. Also, because of the correlation between these parameters and GPS, these parameters might be used as a predictor factor. (C) 2008 The WJG Press. All rights reserved.
引用
收藏
页码:3633 / 3641
页数:9
相关论文
共 32 条
[1]   Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells) [J].
Ahrén, B ;
Havel, PJ .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1999, 277 (04) :R959-R966
[2]   Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Takahashi, M ;
Maeda, K ;
Miyagawa, J ;
Hotta, K ;
Shimomura, I ;
Nakamura, T ;
Miyaoka, K ;
Kuriyama, H ;
Nishida, M ;
Yamashita, S ;
Okubo, K ;
Matsubara, K ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) :79-83
[3]   Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study [J].
Bolukbas, FF ;
Kilic, H ;
Bolukbas, C ;
Gumus, M ;
Horoz, M ;
Turhal, NMS ;
Kavakli, B .
BMC CANCER, 2004, 4 (1)
[4]   Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer [J].
Brown, DR ;
Berkowitz, DE ;
Breslow, MJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :162-166
[5]   Leptin and resistin: Master enemy adipokines unified in brain to control glucose homeostasis [J].
Burcelin, Remy .
ENDOCRINOLOGY, 2008, 149 (02) :443-444
[6]   Circulating adiponectin and endometrial cancer risk [J].
Dal Maso, L ;
Augustin, LSA ;
Karalis, A ;
Talamini, R ;
Franceschi, S ;
Trichopoulos, D ;
Mantzoros, CS ;
La Vecchia, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) :1160-1163
[7]   Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects [J].
Faraj, M ;
Havel, PJ ;
Phélis, S ;
Blank, D ;
Sniderman, AD ;
Cianflone, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) :1594-1602
[8]   Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer [J].
Forrest, LM ;
McMillan, DC ;
McArdle, CS ;
Angerson, WJ ;
Dunlop, DJ .
BRITISH JOURNAL OF CANCER, 2004, 90 (09) :1704-1706
[9]   Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer [J].
Forrest, LM ;
McMillan, DC ;
McArdle, CS ;
Angerson, WJ ;
Dunlop, DJ .
BRITISH JOURNAL OF CANCER, 2003, 89 (06) :1028-1030
[10]   Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia [J].
Garcia, JM ;
Garcia-Touza, M ;
Hijazi, RA ;
Taffet, G ;
Epner, D ;
Mann, D ;
Smith, RG ;
Cunningham, GR ;
Marcelli, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2920-2926